87
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Antipsychotics and risk of venous thromboembolism: A population-based case-control study

, , , &
Pages 19-26 | Published online: 13 Mar 2009

References

  • SahaSChantDWelhamJMcGrathJA systematic review of the prevalence of schizophreniaPLoS Med200525e14115916472
  • HennekensCHHennekensARHollarDCaseyDESchizophrenia and increased risks of cardiovascular diseaseAm Heart J200515061115112116338246
  • ZornbergGLJickHAntipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control studyLancet200035692371219122311072939
  • LiperotiRPedoneCLapaneKLMorVBernabeiRGambassiGVenous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agentsArch Intern Med2005165222677268216344428
  • WalkerAMLanzaLLArellanoFRothmanKJMortality in current and former users of clozapineEpidemiology1997866716779345668
  • ParkinLSkeggDCHerbisonGPPaulCPsychotropic drugs and fatal pulmonary embolismPharmacoepidemiol Drug Saf200312864765214762980
  • HamanakaSKamijoYNagaiTMassive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychoticsCirc J200468985085215329507
  • LacutKLe GalGCouturaudFAssociation between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control studyFundam Clin Pharmacol200721664365018034665
  • MasopustJMalýRUrbanAHosákLCermákováEAntipsychotic drugs as a risk factor for venous thromboembolismInt J Psychiatr Clin Pract2006113246249
  • HäggSBateAStåhlMSpigsetOAssociations between venous thromboembolism and antipsychotics: A study of the WHO Database of Adverse Drug ReactionsDrug Saf200831868569418636787
  • JönssonAKBrudinLAhlnerJHedenmalmKErikssonAHäggSAntipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy seriesInt Clin Psychopharmacol200823526326818703935
  • RayJGMamdaniMMYeoELAntipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolismThromb Haemost200288220520912195690
  • HallasJConducting pharmacoepidemiologic research in DenmarkPharmacoepidemiol Drug Saf200110761962311980250
  • RosendaalFRVenous thrombosis: the role of genes, environment, and behaviorHematology Am Soc Hematol Educ Program200511216304352
  • GlynnRJRosnerBComparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolismAm J Epidemiol20051621097598216207808
  • Tillie-LeblondIMarquetteCHPerezTPulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factorsAnn Intern Med2006144639039616549851
  • MotykieGDZebalaLPCapriniJAA guide to venous thromboembolism risk factor assessmentJ Thromb Thrombolysis20009325326210728025
  • AgenoWBecattiniCBrightonTSelbyRKamphuisenPWCardiovascular risk factors and venous thromboembolism: a meta-analysisCirculation200811719310218086925
  • RayJGMamdaniMTsuyukiRTAndersonDRYeoELLaupacisAUse of statins and the subsequent development of deep vein thrombosisArch Intern Med2001161111405141011386889
  • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trialLancet200035592121295130210776741
  • LidegaardOEdstromBKreinerSOral contraceptives and venous thromboembolism: a five-year national case-control studyContraception200265318719611929640
  • FisherESWhaleyFSKrushatWMThe accuracy of Medicare’s hospital claims data: progress has been made, but problems remainAm J Public Health19928222432481739155
  • BeratisSKatrivanouAGourzisPFactors affecting smoking in schizophreniaCompr Psychiatry200142539340211559866
  • PompERRosendaalFRDoggenCJSmoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive useAm J Hematol20088329710217726684
  • CurranSTurnerDMusaSWattisJPsychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groupsInt J Geriatr Psychiatry200520984284716116576
  • HäggSSpigsetOAntipsychotic-induced venous thromboembolism: a review of the evidenceCNS Drugs2002161176577612383032
  • OwensDGAdverse effects of antipsychotic agents. Do newer agents offer advantages?Drugs19965168959308736614
  • WagstaffABrysonHClozapine: a review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agentsCNS Drugs19954370400
  • AgenoWSquizzatoAGarciaDImbertiDEpidemiology and risk factors of venous thromboembolismSemin Thromb Hemost200632765165817024592
  • AllisonDBMentoreJLHeoMAntipsychotic-induced weight gain: a comprehensive research synthesisAm J Psychiatry1999156111686169610553730
  • WallaschofskiHEigenthalerMKieferMHyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot studyJ Clin Psychopharmacol200323547948314520125
  • AxelssonSHäggSErikssonACLindahlTLWhissPAIn vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulationClin Exp Pharmacol Physiol200734877578017600556
  • CattaneoMHyperhomocysteinemia and venous thromboembolismSemin Thromb Hemost200632771672317024599
  • HaidemenosAKontisDGaziAKallaiEAllinMLuciaBPlasma homocysteine, folate and B12 in chronic schizophreniaProg Neuropsychopharmacol Biol Psychiatry20073161289129617597277